Focus Stocks
Express Scripts Closing in to Resistance
Published on Wednesday, 08 February 2012 05:56 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Express Scripts, Inc. (NASDAQ:ESRX) are trading very close to calculated resistance at $52.50 with the current price action closing at just $51.00 placing the stock near levels that make it difficult to buy.
Express Scripts, Inc. (NASDAQ:ESRX) is a full service pharmacy benefit management and specialty managed care company. The Company serves managed care organizations, insurance carriers, third party administrators, employers, and union-sponsored benefit plans.
Express Scripts current stock range is defined by current calculated support defined at $45.93 and by the resistance level at $52.50, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Express Scripts, as the stock is well above support, however, as the stock pulls back towards $45.93 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $52.50 then traders will get an opportunity to enter Express Scripts stock by establishing a position as the stock moves to a higher range.
Related Articles
- The Range Is Tightening in Express Scripts
- Express Scripts Is Approaching its 50 Day Moving Average
- Trading Idea: Key levels for Express Scripts
- Is Express Scripts Close to Support?
- Trading Idea: Is Express Scripts Breaking Down?
- Express Scripts near Support
- Reference Points for Express Scripts
- Is Express Scripts Closing in to Resistance?
- Close to the 50 Day Moving Average: Express Scripts
- Is Express Scripts Breaking Out?
Related Partner Headlines
- Express Scripts (ESRX): Today's Featured Health Services Loser - TheStreet.com
- UPDATE: Citigroup Cuts PT to $60 on Express Scripts on Outlook Update - Benzinga
- Oppenheimer Maintains Outperform Rating, $63 PT for Express Scripts - Benzinga
- Stocks To Watch For May 11 - Benzinga
- Express Scripts (ESRX): Today's Featured Health Services Winner - TheStreet.com
- Express Scripts (ESRX): Today's Featured Health Services Loser - TheStreet.com
- CVS Earnings Climb 8.8% as Customers Switch Pharmacies - Benzinga
- Express Scripts (ESRX): Today's Featured Health Services Loser - TheStreet.com
- Express Scripts, Urban Outfitters: S&P Gainers - TheStreet.com
- Express Scripts, Medco Deal Gets FTC Approval - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









